Tag: BioTheryX

BioTheryX begins BTX-A51 phase 1 trial in AML and myelodysplastic syndrome

pharmanewsdaily- January 19, 2020

BTX-A51 phase 1 trial : US biotech company BioTheryX has initiated patient dosing in its first clinical program of its small molecule BTX-A51 in patients ... Read More